Cooper, Keith, Rose, Micah, Harris, Petra, Chorozoglou, Maria and Picot, Joanna (2017) Nivolumab for treating Hodgkin's lymphoma (after ASCT and brentuximab vedotin) (Health Technology Assessment, HTA - 16/56/04) National Institute for Health and Care Research 169pp.
Record type:
Monograph
(Project Report)
Text
Nivolumab for treat Hodgkins lymphoma after ASCT and bremtuximab vedotin
Available under License Other.
Download (3MB)
Text
Nivolumab for treat Hodgkins lymphoma after ASCT and bremtuximab vedotin Erratum
Available under License Other.
Download (1MB)
Text
Nivolumab for treat Hodgkins lymphoma after ASCT and bremtuximab vedotin Addendum
Available under License Other.
Download (897kB)
More information
Published date: 21 April 2017
Related URLs:
Keywords:
Nivolumab, hodgkins lymphoma, ASCT, relapsed or refractory, autologous stem cell transplant, systematic review
Identifiers
Local EPrints ID: 412828
URI: http://eprints.soton.ac.uk/id/eprint/412828
PURE UUID: 0719f83a-7302-4175-8303-445e08130aef
Catalogue record
Date deposited: 02 Aug 2017 16:30
Last modified: 10 Apr 2024 01:44
Export record
Contributors
Author:
Micah Rose
Author:
Petra Harris
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.